News

The U.S. Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. (Scripps News) ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...
The FDA has approved Gilead’s long-anticipated HIV prevention shot, Yeztugo, offering a twice-a-year alternative to daily ...